Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma

Jin-Tao Huang,* Bin-Yan Zhong,* Nan Jiang,* Wan-Ci Li, Shuai Zhang, Yu Yin, Jun Yang, Jian Shen, Wan-Sheng Wang, Xiao-Li Zhu Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China*These authors c...

Full description

Bibliographic Details
Main Authors: Huang JT, Zhong BY, Jiang N, Li WC, Zhang S, Yin Y, Yang J, Shen J, Wang WS, Zhu XL
Format: Article
Language:English
Published: Dove Medical Press 2022-11-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
transarterial chemoembolization
immune checkpoint inhibitors
tyrosine kinase inhibitors
Online Access:https://www.dovepress.com/transarterial-chemoembolization-combined-with-immune-checkpoint-inhibi-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/transarterial-chemoembolization-combined-with-immune-checkpoint-inhibi-peer-reviewed-fulltext-article-JHC

Similar Items